Radical prostatectomy or watchful waiting in early prostate cancer

New England Journal of Medicine

Volumn 370, Issue 10, 2014, Pages 932-942

  Bill Axelson, Anna ^a   Holmberg, Lars ^a,g   Garmo, Hans ^a,g   Rider, Jennifer R ^h,i   Taari, Kimmo ^j   Busch, Christer ^a   Nordling, Stig ^k   Hag̈gman, Michael ^a   Andersson, Swen Olof ^b,c   Span̊gberg, Anders ^d   Andreń, Ove ^b,c   Palmgren, Juni ^e   Steineck, Gunnar ^e,f   Adami, Hans Olov ^e,i   Johansson, Jan Erik ^b,c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^k UNIVERSITY OF HELSINKI   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN;

AGE DISTRIBUTION; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; EARLY CANCER; GLEASON SCORE; HUMAN; LAMINECTOMY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTER STUDY; ORCHIECTOMY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL;

AGE FACTORS; AGED; ANDROGEN ANTAGONISTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PALLIATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK; SURVIVORS; WATCHFUL WAITING;

EID: 84895473498     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1311593     Document Type: Article

References (17)

1. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011;364:1708-17.
2. Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012;367:203-13. [Erratum, N Engl J Med 2012;367:582.]
3. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347:781-9. (Pubitemid 34988336)
4. Bill-Axelson A, Holmberg L, Filén F, et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial. J Natl Cancer Inst 2008;100:1144-54.
5. Harmer MH, ed. TNM classification of malignant tumours. 3rd ed. Geneva: International Union against Cancer, 1978.
6. Brendler CB, Cleeve LK, Anderson EE, Paulson DF. Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. J Urol 1980;124:849-50. (Pubitemid 11210570)
7. Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983;4:473-85. (Pubitemid 14236144)
8. Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M, ed. Urologic pathology: the prostate. Philadelphia: Lea & Febiger, 1977:171-98.
9. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.
10. Kalbfleisch JD, Prentice RL, eds. The statistical analysis of failure time data. 2nd ed. New York: John Wiley, 2002.
11. Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002;347:790-6. (Pubitemid 34988337)
12. Johansson E, Bill-Axelson A, Holmberg L, Onelöv E, Johansson JE, Steineck G. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial. Eur Urol 2009;55:422-30.
13. Bill-Axelson A, Garmo H, Holmberg L, et al. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 Randomized Clinical Trial. Eur Urol 2013;64:920-8.
14. Johansson E, Steineck G, Holmberg L, et al. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol 2011;12:891-9.
15. Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000;283:354-60. (Pubitemid 30051753)
16. Horwich A, Hugosson J, de Reijke T, Wiegel T, Fizazi K, Kataja V. Prostate cancer: ESMO Consensus Conference Guidelines 2012. Ann Oncol 2013;24:1141-62.
17. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358:1250-61. (Pubitemid 351439226)